CompletedNot Applicable

Treatment Outcomes of MicroPulse Trans-scleral Cyclophotocoagulation in Uncontrolled Glaucoma

Canada52 participantsStarted 2017-06-19

Plain-language summary

The goal of this study is to evaluate the efficacy and safety of the novel form of trans-scleral cyclophotocoagulation using micropulse diode laser and trans-pars plana treatment (Micropulse TSCPC, mTSCPC MP3, IRIDEX CYCLO G6™ Glaucoma Laser System, CA, USA) in adults for the treatment of uncontrolled glaucoma.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. mild glaucoma: IOP \> 18 mmHg
✓. moderate glaucoma: IOP \> 15 mmHg
✓. advanced glaucoma: IOP \> 12 mmHg

What they're measuring

Intraocular Pressure (IOP)

Timeframe: 18 months

Trial details

NCT IDNCT03187418

SponsorCentre hospitalier de l'Université de Montréal (CHUM)

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-02-15

Results submitted2021-08-05

View on ClinicalTrials.gov More Glaucoma trials